301509 金凯生科
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.49011.38320.40313.85722.822
总资产报酬率 ROA (%)1.3979.86015.32110.09315.153
投入资产回报率 ROIC (%)1.47210.88118.10912.09719.516

边际利润分析
销售毛利率 (%)41.72447.20544.10740.14940.394
营业利润率 (%)13.09926.56627.05018.10215.500
息税前利润/营业总收入 (%)11.21326.09824.33819.07417.060
净利润/营业总收入 (%)12.24922.63522.52815.39512.690

收益指标分析
经营活动净收益/利润总额(%)86.394103.28498.93096.183106.065
价值变动净收益/利润总额(%)20.9792.337-0.188-0.041-0.059
营业外收支净额/利润总额(%)-0.165-0.151-0.0480.426-4.772

偿债能力分析
流动比率 (X)14.62915.3672.8493.6562.295
速动比率 (X)13.02913.5721.9712.4271.723
资产负债率 (%)6.3876.04327.37321.58333.602
带息债务/全部投入资本 (%)-0.0020.5189.10810.07613.134
股东权益/带息债务 (%)-4,402,459.86919,040.990975.309879.856651.100
股东权益/负债合计 (%)1,465.7401,554.818265.328363.333197.601
利息保障倍数 (X)-6.012-61.072-9.01821.3247.529

营运能力分析
应收账款周转天数 (天)65.23437.25736.69052.56553.793
存货周转天数 (天)246.640199.544184.278169.834171.615